共有 50 笔近期内部人交易记录记录，涉及 Shattuck Labs, Inc. (STTK), 包括 32 笔买入 和 15 笔卖出. 内部人买入总额为 $17.94M 内部人卖出总额为 $1.46M.
近期活跃的重要内部人包括 Deyoung Casi, Neill Andrew R, Pandite Arundathy N.. 内部人交易记录可以揭示公司管理层对股票估值和未来前景的看法.
内部人交易记录 — STTK
| 日期 |
姓名 |
职位 |
交易类型 |
股数 |
平均价格 |
总价值 |
持股数量 |
| 2026-01-25 |
Deyoung Casi |
Chief Business Officer |
RSU 预扣税 |
2,286 |
$4.15 |
$9.49K |
73,480 |
| 2026-01-25 |
Neill Andrew R |
Chief Financial Officer |
RSU 预扣税 |
2,589 |
$4.15 |
$10.74K |
228,224 |
| 2026-01-25 |
Pandite Arundathy N. |
Chief Medical Officer |
RSU 预扣税 |
3,195 |
$4.15 |
$13.26K |
196,219 |
| 2026-01-25 |
Stout Stephen |
See Remarks |
RSU 预扣税 |
593 |
$4.15 |
$2.46K |
81,529 |
| 2026-01-10 |
Schreiber Taylor |
Chief Executive Officer |
限制性股票授予 (RSU) |
1,548,300 |
$4.75 |
$7.35M |
1,548,300 |
| 2026-01-10 |
Deyoung Casi |
Chief Business Officer |
RSU 预扣税 |
5,699 |
$4.75 |
$27.07K |
75,766 |
| 2026-01-10 |
Neill Andrew R |
Chief Financial Officer |
RSU 预扣税 |
6,660 |
$4.75 |
$31.64K |
230,813 |
| 2026-01-10 |
Pandite Arundathy N. |
Chief Medical Officer |
RSU 预扣税 |
6,851 |
$4.75 |
$32.54K |
199,414 |
| 2026-01-10 |
Shukla Abhinav A. |
Chief Technical Officer |
限制性股票授予 (RSU) |
315,500 |
$4.75 |
$1.5M |
315,500 |
| 2026-01-10 |
Stout Stephen |
See Remarks |
RSU 预扣税 |
4,153 |
$4.75 |
$19.73K |
82,122 |
| 2025-08-28 |
Ashiya Mona |
Director |
限制性股票授予 (RSU) |
66,300 |
$0.99 |
$65.64K |
66,300 |
| 2025-08-28 |
Baker Daniel G. |
Director |
限制性股票授予 (RSU) |
66,300 |
$0.99 |
$65.64K |
66,300 |
| 2025-08-25 |
Redmile Group, Llc |
10 Percent Owner |
限制性股票授予 (RSU) |
4,097,730 |
$1.08 |
$4.44M |
4,097,730 |
| 2025-08-25 |
Siegall Clay B |
Director |
限制性股票授予 (RSU) |
128,054 |
$1.08 |
$138.89K |
128,054 |
| 2025-08-25 |
Schreiber Taylor |
Chief Executive Officer |
限制性股票授予 (RSU) |
25,610 |
$1.08 |
$27.78K |
25,610 |
| 2025-08-25 |
Neill Andrew R |
Chief Financial Officer |
限制性股票授予 (RSU) |
64,027 |
$1.08 |
$69.44K |
64,027 |
| 2025-08-25 |
Shukla Abhinav A. |
Chief Technical Officer |
限制性股票授予 (RSU) |
5,122 |
$1.08 |
$5.56K |
5,122 |
| 2025-08-25 |
Stout Stephen |
See Remarks |
限制性股票授予 (RSU) |
12,805 |
$1.08 |
$13.89K |
12,805 |
| 2025-08-25 |
Orbimed Advisors Llc |
Director |
未知 |
- |
- |
- |
- |
| 2025-08-25 |
Orbimed Advisors Llc |
Director |
知情买入 |
1,051,021 |
$0.87 |
$911.97K |
1,051,021 |
| 2025-08-25 |
Ashiya Mona |
Officer |
未知 |
- |
- |
- |
- |
| 2025-08-25 |
Ashiya Mona |
Director |
知情买入 |
1,051,021 |
$0.87 |
$911.97K |
1,051,021 |
| 2025-08-25 |
Baker Daniel G. |
Officer |
未知 |
- |
- |
- |
- |
| 2025-07-14 |
Siegall Clay B |
Director |
限制性股票授予 (RSU) |
33,150 |
$0.82 |
$27.18K |
33,150 |
| 2025-07-14 |
Redmile Group, Llc |
10 Percent Owner |
限制性股票授予 (RSU) |
33,150 |
$0.82 |
$27.18K |
33,150 |
| 2025-07-14 |
Gibson Neil W |
Director |
限制性股票授予 (RSU) |
33,150 |
$0.82 |
$27.18K |
33,150 |
| 2025-07-14 |
Golumbeski George |
Director |
限制性股票授予 (RSU) |
33,150 |
$0.82 |
$27.18K |
33,150 |
| 2025-07-14 |
Boudreau Helen M |
Director |
限制性股票授予 (RSU) |
33,150 |
$0.82 |
$27.18K |
33,150 |
| 2025-07-14 |
Lee Michael Stewart |
Director |
限制性股票授予 (RSU) |
33,150 |
$0.82 |
$27.18K |
33,150 |
| 2025-07-14 |
Brous Tyler |
Director |
限制性股票授予 (RSU) |
33,150 |
$0.82 |
$27.18K |
33,150 |
| 2025-07-14 |
Brownstein Carrie |
Director |
限制性股票授予 (RSU) |
33,150 |
$0.82 |
$27.18K |
33,150 |
| 2025-07-14 |
Sasser Amy Kate |
Director |
限制性股票授予 (RSU) |
33,150 |
$0.82 |
$27.18K |
33,150 |
| 2025-01-28 |
Schreiber Taylor |
Chief Executive Officer |
限制性股票授予 (RSU) |
684,600 |
$1.18 |
$807.83K |
684,600 |
| 2025-01-28 |
Deyoung Casi |
Chief Business Officer |
限制性股票授予 (RSU) |
194,300 |
$1.18 |
$229.27K |
194,300 |
| 2025-01-28 |
Neill Andrew R |
Chief Financial Officer |
限制性股票授予 (RSU) |
214,000 |
$1.18 |
$252.52K |
214,000 |
| 2025-01-28 |
Pandite Arundathy N. |
Chief Medical Officer |
限制性股票授予 (RSU) |
206,200 |
$1.18 |
$243.32K |
206,200 |
| 2025-01-28 |
Shukla Abhinav A. |
Chief Technical Officer |
限制性股票授予 (RSU) |
165,200 |
$1.18 |
$194.94K |
165,200 |
| 2025-01-28 |
Stout Stephen |
See Remarks |
限制性股票授予 (RSU) |
177,000 |
$1.18 |
$208.86K |
177,000 |
| 2025-01-25 |
Deyoung Casi |
Chief Business Officer |
RSU 预扣税 |
2,297 |
$1.16 |
$2.66K |
81,465 |
| 2025-01-25 |
Pandite Arundathy N. |
Chief Medical Officer |
RSU 预扣税 |
3,211 |
$1.16 |
$3.72K |
206,265 |
| 2025-01-25 |
Shukla Abhinav A. |
Chief Technical Officer |
RSU 预扣税 |
2,261 |
$1.16 |
$2.62K |
73,536 |
| 2025-01-10 |
Deyoung Casi |
Chief Business Officer |
RSU 预扣税 |
5,727 |
$1.19 |
$6.82K |
83,762 |
| 2025-01-10 |
Pandite Arundathy N. |
Chief Medical Officer |
RSU 预扣税 |
6,884 |
$1.19 |
$8.19K |
209,476 |
| 2025-01-10 |
Shukla Abhinav A. |
Chief Technical Officer |
RSU 预扣税 |
4,830 |
$1.19 |
$5.75K |
74,597 |
| 2024-12-04 |
Redmile Group, Llc |
10 Percent Owner |
其他（卖出） |
1,026,888 |
$1.25 |
$1.28M |
4,512,836 |
| 2024-10-07 |
Schreiber Taylor |
Chief Executive Officer |
知情买入 |
36,500 |
$1.21 |
$44.22K |
71,002 |
| 2024-06-28 |
Brous Tyler |
Director |
知情买入 |
3,000 |
$3.90 |
$11.7K |
238,088 |
| 2024-06-27 |
Brous Tyler |
Director |
知情买入 |
5,416 |
$3.89 |
$21.07K |
235,088 |
| 2024-06-26 |
Schreiber Taylor |
Chief Executive Officer |
知情买入 |
14,400 |
$3.47 |
$50.01K |
34,502 |
| 2024-06-21 |
Siegall Clay B |
Director |
限制性股票授予 (RSU) |
27,700 |
$4.37 |
$121.05K |
27,700 |
■ 知情交易 — 公开市场买卖（最具参考价值）
■ 非知情买入 — 奖励、期权行权、转换
■ 非知情卖出 — 税务代扣、归属出售
■ 中性 — 礼赠、信托、到期
